CDC Report: Progress on methicillin-resistant staph aureus (MRSA) infections slows
CDC reports claim that from 2005 to 2013, the rates of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections declined on average 17.1% every year. However, CDC reports that this decline stopped and the rate reached a plateau. "Staph infections are a serious threat and can be deadly," CDC Director Dr. Robert Redfield said in a news release. "U.S. hospitals have made significant progress, but this report tells us that all staph infections must remain a prevention priority for healthcare providers." According to the report, the rates of decline for MRSA diagnosis in communities across the country are even smaller: 6.9% annually from 2005 to 2016. The authors of the report suggest that the increase in staph infections in the community might be linked to the nation's opioid crisis.@ https://amp.cnn.com/cnn/2019/03/05/health/staph-infections-cdc/index.html" rel="nofollow noopener noreferrer" target="_blank">https://amp.cnn.com/cnn/2019/03/05/health/staph-infections-cdc/index.html
Progress on deadly staph infections slows; CDC calls for increased prevention
More than 119,000 people were diagnosed with bloodstream Staphylococcus aureus infections in the United States in 2017, and almost 20,000 died — a significant slowing in the previously declining rates of infections with the bacteria.